2022年発表論文
2022.02.26
2022年に当教室で発表した和文論文です。
題名(論文名) | 著者 | 掲載雑誌 |
---|
2021年に当教室で発表した英文論文です(2022年4月2日現在)。
題名(論文名) | 著者 | 掲載雑誌 |
---|---|---|
Treatment Outcomes in Neuroendocrine Prostate Cancer. |
Iwamoto H, Nakagawa R, Makino T, Kadomoto S, Yaegashi H, Nohara T, Shigehara K, Izumi K, Kadono Y, Mizokami A. |
Anticancer Res. 2022 Apr;42(4):2167-2176. doi: 10.21873/anticanres.15699. PMID: 35347041 |
Favorable Response of Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma with Only Small Lesions to not be Considered Measurable by RECIST. |
Kadono Y, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kamijima T, Seto C, Takano A, Yotsuyanagi S, Nakagawa R, Miyagi T, Aoyama S, Asahi H, Fukuda R, Mizokami A. |
Urol J. 2022 doi: 10.22037/uj.v18i.6652. |
Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer. |
Shimada T, Izumi K, Kano H, Kadomoto S, Makino T, Naito R, Iwamoto H, Yaegashi H, Kadono Y, Mizokami A. |
Anticancer Res. 2022; 42(2): 1065-1071. |
Analysis of the Safety of Pegfilgrastim Addition in Bleomycin, Etoposide, and Cisplatin Treatment Patients With Germ Cell Tumors. |
Nakagawa R, Iwamoto H, Makino T, Kadomoto S, Yaegashi H, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Mizokami A. |
Front Oncol. 2022; 11:770067. |